3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
6
Neoplasm Metastasis
3
Advanced Malignant Solid Tumors
3
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Inflammatory Breast Neoplasms
1
HER2+ Metastatic Breast Cancer (MBC)
1
HER2 Positive Breast Carcinoma
1
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
neratinib
×
Clear all
No trials found.